Advertisement

Topics

COSMIX molecular biologicals GmbH Company Profile

07:59 EST 24th November 2017 | BioPortfolio

COSMIX identifies and improves peptides for applications in healthcare, research, and industry. Peptides are high potential product candidates and well characterized in many applications.
COSMIX’s strong and unique technology platforms enable the generation of innovative, tailored peptide products.

Location

Inhoffenstrasse 7
Braunschweig
D-38124
Germany

Contact

Phone: 49 (0)531-120 86-0
Fax: 49 (0)531-120 86-99
Email: info@cosmix.de


News Articles [612 Associated News Articles listed on BioPortfolio]

Australia’s TGA consults on naming of biologicals

Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA), announced on 28 July 2017 that it was opening a consultation on how to name biologicals.

Switching to biosimilars in Nordic countries

In the European Union (EU), decisions on the interchangeability or substitution of biosimilars and originator biologicals are not made by the European Medicines Agency (EMA), but at the national level...

Switching approaches to biosimilars in Nordic countries

In the European Union (EU), decisions on the interchangeability or substitution of biosimilars and originator biologicals are not made by the European Medicines Agency (EMA), but at the national level...

Hummingbird Diagnostics and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers

Hummingbird Diagnostics GmbH, specialized in early disease detection using molecular markers derived from blood, and Saarland University agreed on a comprehensive framework agreement regarding an expa...

Amgen and Simcere to collaborate on copy biologicals in China

Biotech giant Amgen and China-based Simcere Pharmaceutical Group (Simcere) announced on 26 September 2017 that they have made an exclusive agreement to co-develop and commercialize four copy biologica...

Molecular Devices and Cytena Partner collaborate in single cell printing

Molecular Devices, LLC announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This system utilizes microfluidics-based technology and real-time ...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

NHS England to increase biosimilar usage

On 12 September 2017, National Health Service (NHS) England released a ‘Commissioning framework for biological medicines (including biosimilar medicines)’. In this document, they make a serie...

PubMed Articles [702 Associated PubMed Articles listed on BioPortfolio]

Dr. Chi-Ming Chu: Respected founder of molecular virology and pioneer of biologicals in China.

Biologicals in the Treatment of Bronchial Asthma.

Biologicals are a therapeutic option for patients with severe asthma. Difficult asthma in patients with untreated comorbidities or persistent trigger factors is much more common than severe refractory...

Clinical development of biologicals and biosimilars - safety concerns.

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics.

Biologicals are a rapidly expanding class of medications used in the treatment of many different conditions. This article reviews the common characteristics of this class and the requirements for safe...

Clinical Trials [1402 Associated Clinical Trials listed on BioPortfolio]

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Companies [1374 Associated Companies listed on BioPortfolio]

COSMIX molecular biologicals GmbH

COSMIX identifies and improves peptides for applications in healthcare, research, and industry. Peptides are high potential product candidates and well characterized in many applications.COSMIX’s st...

MicroDiscovery GmbH

Based in Berlin, MicroDiscovery GmbH is a leading supplier of bioinformatics solutions in the field of functional genomics. Launched in 2000 as a spin-off from the Max Planck Institute for Molecular G...

Fermentas GmbH

FERMENTAS is a world leader in the discovery, manufacturing and marketing of quality molecular biologicals and providing services to the international research community. As a dynamically evolving bio...

Cosmix

Phage-display based services including custom mouse Fab antibodies

Trait Genetics GmbH

TraitGenetics GmbH is the result of increasing demand for molecular marker analysis in plant breeding and biodiversity research. The company was established in 2000 and started to become operational i...

More Information about "COSMIX molecular biologicals GmbH" on BioPortfolio

We have published hundreds of COSMIX molecular biologicals GmbH news stories on BioPortfolio along with dozens of COSMIX molecular biologicals GmbH Clinical Trials and PubMed Articles about COSMIX molecular biologicals GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of COSMIX molecular biologicals GmbH Companies in our database. You can also find out about relevant COSMIX molecular biologicals GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record